Hong Kong, China vs Singapore: Cases started on MDR-TB treatment
Hong Kong, China
19
in 2024
Singapore
22
in 2024
Hong Kong, China rank
106th
Singapore rank
104th
Cases started on MDR-TB treatment over time
- Hong Kong, China
- Singapore
How they compare
Singapore currently reports 22 against 19 in Hong Kong, China, a difference of 3.
That makes Singapore's figure about 1.2 times Hong Kong, China's.
The two have swapped places 5 times across 17 shared years of data; in 2008 it was Hong Kong, China ahead.
Hong Kong, China ranks 106th and Singapore ranks 104th of 193 countries.
Hong Kong, China has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Hong Kong, China | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.5 | 3.5 | 23 | Hong Kong, China |
| 2010s | 26.2 | 13.6 | 12.6 | Hong Kong, China |
| 2020s | 24.4 | 19.4 | 5 | Hong Kong, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Hong Kong, China or Singapore?
- Singapore, at 22 against 19 in Hong Kong, China as of 2024.
- What is the difference in cases started on mdr-tb treatment between Hong Kong, China and Singapore?
- 3, with Singapore ahead.
- How many years of comparable data are there for Hong Kong, China and Singapore?
- 17 years are reported by both, from 2008 to 2024.
- How do Hong Kong, China and Singapore rank globally for cases started on mdr-tb treatment?
- Hong Kong, China ranks 106th and Singapore ranks 104th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.